Ragisha Gopalakrishnan, MD, is a medical oncologist and hematologist affiliated with Beth Israel Lahey Health/Lahey Hospital & Medical Center and Mount Sinai Medical Center. Her clinical practice centers on breast oncology, systemic anticancer therapies across the care continuum, and the evaluation and management of hematologic conditions. Dr. Gopalakrishnan’s research interests focus on cancer outcomes and biologic drivers of treatment response, health equity and disparities in oncology care, and the use of digital innovation and artificial intelligence to improve symptom monitoring and survivorship. She has contributed to ASCO clinical practice guidelines and serves in national leadership and collaborative roles with NRG Oncology and the NCI Gastrointestinal Steering Committee. Dr. Gopalakrishnan earned her MD from Albany Medical College, completed an Internal Medicine residency at UT Southwestern Medical Center/Parkland Health and Hospital System, and pursued fellowship training in Hematology/Oncology at Vanderbilt University Medical Center (Vanderbilt-Ingram Cancer Center).
Medical School
2009 – 2013
Residency
2013 – 2016
Fellowship
2016 – 2019